BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 29, 2012
View Archived Issues
Merck & Co. patents new hPDK1 inhibitors
Read More
New agents for respiratory and other disorders patented by RespiVert
Read More
Treatment duration shortened using combination therapy for HCV
Read More
Transgene presents preclinical results for new therapeutic Ad5-based HBV vaccine
Read More
Novel arginase inhibitors prepared at Mars
Read More
Inhibitors of H-PGDS prove effective for asthma therapy
Read More
Novel potassium channel blockers disclosed by Merck & Co.
Read More
Scientists at Merck & Co. produce new mGlu5 receptor modulators
Read More
Japanese scientists discover novel protein kinase inhibitors
Read More
Takeda launches Azilva in Japan
Read More
CHMP supports monotherapy indication for Eisai's antiepileptic agent Zonegran
Read More
EMA recommends approval for AMPA receptor antagonist Fycompa
Read More
Poteligeo injection launched in Japan for adult T-cell leukemia-lymphoma
Read More
Shionogi launches injectable oxycodone product in Japan
Read More
Meiji Seika Pharma licenses COPD drug rights in Japan
Read More
Octreotide tested in patients with severe acute pancreatitis
Read More
FDA approves Absorica for severe recalcitrant nodular acne
Read More
Kalydeco recommended for E.U. approval
Read More
Anti-hepatitis C virus activity observed with raloxifene
Read More
European CHMP recommends approval of Jentadueto
Read More
Summit commences trial of potential disease-modifying drug for Duchenne muscular dystrophy
Read More
Ferring and Kyowa Hakko Kirin to copromote nocturnal enuresis drug in Japan
Read More
EMA grants positive opinion to Pfizer's Inlyta for kidney cancer
Read More
Pfizer's Xalkori capsules now available in Japan for ALK-positive NSCLC
Read More
NICE publishes new guideline regarding prescription of opioids for palliative care
Read More
ULISES 008 study misses primary endpoint
Read More